Corporate News 24-May-17
Orchid Pharma receives ANDA approval for Aripiprazole Tablets
From USFDA
Orchid Pharma has received ANDA approval from USFDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.
Previous News
Orchid Pharma reports consolidated net loss of Rs 30.90 crore in the June 2021 quarter
( Results - Announcements 14-Aug-21 12:43 )
Orchid Pharma consolidated net profit rises 287.75% in the December 2023 quarter
( Results - Announcements 08-Feb-24 17:29 )
Broader mkt underperforms; metal stocks lose shine
( Market Commentary - Mid-Session 23-Jun-23 11:35 )
Orchid Pharma to conduct board meeting
( Corporate News - 13-Jul-21 09:47 )
Orchid Pharma launches QIP issue
( Corporate News - 23-Jun-23 10:12 )
Orchid Pharma schedules board meeting
( Corporate News - 09-Nov-21 17:12 )
Orchid Pharma hits the roof on launching QIP issue
( Hot Pursuit - 23-Jun-23 11:26 )
Orchid Pharma reports standalone net loss of Rs 187.85 crore in the March 2017 quarter
( Results - Announcements 05-Jun-17 16:40 )
Orchid Chemicals & Pharmaceuticals announces change in directorate
( Corporate News - 01-Jun-15 19:05 )
Orchid Pharma to declare Quarterly Result
( Corporate News - 25-May-19 10:31 )
Orchid Pharma to discuss results
( Corporate News - 10-Aug-21 11:07 )
Other Stories
Gujarat Toolroom to conduct EGM
08-Jul-24 19:53
Macro Intl. to conduct AGM
08-Jul-24 19:52
Ecoboard Industries schedules AGM
08-Jul-24 19:52
Eraaya Lifespaces schedules EGM
08-Jul-24 19:52
Binny to convene EGM
08-Jul-24 19:52
ICRA upgrades long term rating on bank facilities of Keystone Realtors
08-Jul-24 19:17
Sadbhav Engineering schedules EGM
08-Jul-24 19:08
Board of Va Tech Wabag approves divestment of Wabag Romania
08-Jul-24 19:08
Global Capital Markets to announce Quarterly Result
08-Jul-24 19:07
Motherson Sumi Wiring India schedules board meeting
08-Jul-24 19:07
Back
Top
